HK1097746A1 - Oligopeptides as coating material for medical products - Google Patents

Oligopeptides as coating material for medical products

Info

Publication number
HK1097746A1
HK1097746A1 HK07104047.8A HK07104047A HK1097746A1 HK 1097746 A1 HK1097746 A1 HK 1097746A1 HK 07104047 A HK07104047 A HK 07104047A HK 1097746 A1 HK1097746 A1 HK 1097746A1
Authority
HK
Hong Kong
Prior art keywords
oligopeptides
coating material
medical products
medical
products
Prior art date
Application number
HK07104047.8A
Other languages
English (en)
Inventor
Erika Hoffmann
Michael Hoffmann
Roland Horres
Original Assignee
Hemoteq Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemoteq Ag filed Critical Hemoteq Ag
Publication of HK1097746A1 publication Critical patent/HK1097746A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07104047.8A 2003-10-07 2007-04-18 Oligopeptides as coating material for medical products HK1097746A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/680,035 US20090232866A1 (en) 2003-10-07 2003-10-07 Oligopeptides as coating material for medical products
PCT/EP2004/011117 WO2005039629A2 (en) 2003-10-07 2004-10-05 Caspase inhibitors as coating materiel for medical products for inhibiting restenosis

Publications (1)

Publication Number Publication Date
HK1097746A1 true HK1097746A1 (en) 2007-07-06

Family

ID=34520532

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104047.8A HK1097746A1 (en) 2003-10-07 2007-04-18 Oligopeptides as coating material for medical products

Country Status (16)

Country Link
US (1) US20090232866A1 (xx)
EP (2) EP2380586B1 (xx)
JP (1) JP4861182B2 (xx)
KR (1) KR20070019947A (xx)
CN (1) CN1889974B (xx)
AU (1) AU2004283427B8 (xx)
CA (1) CA2542913C (xx)
EA (1) EA010499B1 (xx)
ES (1) ES2549389T3 (xx)
HK (1) HK1097746A1 (xx)
IL (1) IL174603A (xx)
MX (1) MXPA06003889A (xx)
NZ (1) NZ546315A (xx)
PL (1) PL2380586T3 (xx)
WO (1) WO2005039629A2 (xx)
ZA (1) ZA200603110B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8367108B2 (en) 2006-09-01 2013-02-05 Bezwada Biomedical, Llc Functionalized non-phenolic amino acids and absorbable polymers therefrom
US7939505B2 (en) 2007-05-04 2011-05-10 Marina Biotech, Inc. Amino acid lipids and uses thereof
BRPI0922344A2 (pt) * 2008-12-19 2017-10-24 3B Pharmaceuticals Gmbh inibidores de tfpi e métodos de uso
ES2983470T3 (es) 2010-03-19 2024-10-23 Takeda Pharmaceuticals Co Inhibidores del TFPI y métodos de uso
ES2686820T3 (es) * 2012-01-03 2018-10-22 Neostrata Company, Inc. Derivados de N-acilpéptido y sus usos
JP2015514070A (ja) 2012-03-21 2015-05-18 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉ阻害剤および使用方法
CN106730049B (zh) * 2016-12-22 2020-05-12 深圳汉诺医疗科技有限公司 一种生物相容性内置支架材料
CN113521286B (zh) * 2020-07-20 2023-08-18 中国医学科学院基础医学研究所 冠状病毒蛋白酶抑制剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890546B2 (en) * 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
EP1191939B1 (en) * 1999-03-24 2007-10-17 Zengen, Inc. Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
WO2000061542A1 (en) * 1999-04-09 2000-10-19 Cytovia, Inc. Caspase inhibitors and the use thereof
DE19950386A1 (de) * 1999-10-19 2001-05-10 Miladin Lazarov Biokompatibler Gegenstand
EP1253946A2 (en) * 2000-02-10 2002-11-06 Alexion Pharmaceuticals, Inc. Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
US20040161443A1 (en) * 2001-04-17 2004-08-19 Macneil Sheila Vehicle
WO2003020223A2 (en) * 2001-09-05 2003-03-13 James Lipton A cancer treatment system
ATE428372T1 (de) * 2001-10-15 2009-05-15 Hemoteq Ag Beschichtung von stents zur verhinderung von restenose
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
CA2511223A1 (en) * 2002-01-16 2003-07-31 The Board Of Regents, The University Of Texas System Thrombin derived peptides for promoting cardiac tissue repair
CN1326577C (zh) * 2002-02-28 2007-07-18 诺瓦提斯公司 N－{5－[4－(4－甲基－哌嗪－1－基甲基)－苯甲酰氨基]－2－甲基苯基}－4－(3－吡啶基)－2－嘧啶－胺涂层的支架
US7361339B2 (en) * 2003-01-09 2008-04-22 Alexion Pharmaceuticals, Inc. Methods for reducing morality associated with acute myocardial infarction

Also Published As

Publication number Publication date
PL2380586T3 (pl) 2015-12-31
CN1889974B (zh) 2012-08-29
EP2380586A3 (en) 2012-01-04
IL174603A (en) 2010-12-30
JP2007507264A (ja) 2007-03-29
EP2380586B1 (en) 2015-07-15
ES2549389T3 (es) 2015-10-27
CN1889974A (zh) 2007-01-03
WO2005039629A3 (en) 2005-06-23
AU2004283427A1 (en) 2005-05-06
AU2004283427B2 (en) 2008-12-11
EP2380586A2 (en) 2011-10-26
CA2542913A1 (en) 2005-05-06
JP4861182B2 (ja) 2012-01-25
IL174603A0 (en) 2006-08-20
EA200600549A1 (ru) 2006-10-27
MXPA06003889A (es) 2006-08-11
WO2005039629A2 (en) 2005-05-06
EA010499B1 (ru) 2008-10-30
CA2542913C (en) 2015-01-06
AU2004283427B8 (en) 2009-01-29
EP1670502A2 (en) 2006-06-21
ZA200603110B (en) 2007-12-27
US20090232866A1 (en) 2009-09-17
KR20070019947A (ko) 2007-02-16
NZ546315A (en) 2009-06-26

Similar Documents

Publication Publication Date Title
GB0315457D0 (en) Biological products
EP1615615A4 (en) PHARMACEUTICAL PRODUCTS
GB0303337D0 (en) Biological products
IL173766A0 (en) Pharmaceutical products comprising bisphosphonates
ZA200509099B (en) Stabilized pharmaceutical product
GB0225279D0 (en) Biological products
GB0224082D0 (en) Biological products
GB0305133D0 (en) Product
GB0325836D0 (en) Biological products
HK1097746A1 (en) Oligopeptides as coating material for medical products
EP1591373A4 (en) PACKAGING MATERIAL
GB0315889D0 (en) Stable pharmaceutical products
EP1516897A4 (en) WATER-BASED COATING MATERIAL FOR RUBBER ARTICLE
EP1645563A4 (en) PROTEIN FOLDING MATERIALS
AU2003264541A1 (en) Medical material
EP1681325A4 (en) COATING MATERIALS
GB0314901D0 (en) Coating material
GB2405853B (en) Material handling
GB0316360D0 (en) Pharmaceutical product
GB0317475D0 (en) Product
GB2447190B (en) Trihalomethionine derivative and pharmaceutical product containing the same
GB0320836D0 (en) Material
GB0319588D0 (en) Biological products
GB0327181D0 (en) Biological products
GB0319587D0 (en) Biological products

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161005